Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes
- PMID: 12086932
- DOI: 10.2337/diabetes.51.7.2045
Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes
Abstract
Peroxisome proliferator-activated receptor (PPAR)-gamma plays an important role in adipogenesis. However, the functions of PPAR-gamma in differentiated adipocytes have remained unclear. The role of PPAR-gamma in mature 3T3-L1 adipocytes was therefore investigated by overexpression of a dominant negative mutant of this protein (PPAR-gamma-DeltaC) that lacks the 16 COOH-terminal amino acids and that has been shown to prevent the thiazolidinedione-induced differentiation of 3T3-L1 cells into adipocytes. Overexpression of PPAR-gamma-DeltaC in mature 3T3-L1 adipocytes by adenovirus gene transfer resulted in a decrease in both cell size and intracellular triglyceride content, an increase in the extent of lipolysis, and a reduction in the rate of free fatty acid uptake. Furthermore, overexpression of this mutant reduced the abundance of mRNAs for several key enzymes that contribute to triglyceride and free fatty acid metabolism as well as the amounts of GLUT4, insulin receptor, insulin receptor substrate (IRS), and C/EBPalpha mRNAs. It also reduced both the concentration of IRS2 and the insulin-stimulated glucose uptake. These results suggest that PPAR-gamma plays an important role in mature 3T3-L1 adipocytes at least in part by maintaining the expression of genes that confer the characteristics of mature adipocytes.
Similar articles
-
Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.Mol Endocrinol. 2001 Oct;15(10):1729-38. doi: 10.1210/mend.15.10.0715. Mol Endocrinol. 2001. PMID: 11579205
-
Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.Diabetes. 2001 May;50(5):1083-92. doi: 10.2337/diabetes.50.5.1083. Diabetes. 2001. PMID: 11334412
-
Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.Ann N Y Acad Sci. 1999 Nov 18;892:134-45. doi: 10.1111/j.1749-6632.1999.tb07792.x. Ann N Y Acad Sci. 1999. PMID: 10842659
-
[Adipocyte differentiation and nuclear receptor].Nihon Rinsho. 1997 Jun;55(6):1596-604. Nihon Rinsho. 1997. PMID: 9200953 Review. Japanese.
-
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.Biochim Biophys Acta. 1996 Jul 26;1302(2):93-109. doi: 10.1016/0005-2760(96)00066-5. Biochim Biophys Acta. 1996. PMID: 8695669 Review.
Cited by
-
CircMEF2C(2, 3) modulates proliferation and adipogenesis of porcine intramuscular preadipocytes by miR-383/671-3p/MEF2C axis.iScience. 2024 Apr 10;27(5):109710. doi: 10.1016/j.isci.2024.109710. eCollection 2024 May 17. iScience. 2024. PMID: 38689646 Free PMC article.
-
Obacunone, a Promising Phytochemical Triterpenoid: Research Progress on Its Pharmacological Activity and Mechanism.Molecules. 2024 Apr 15;29(8):1791. doi: 10.3390/molecules29081791. Molecules. 2024. PMID: 38675611 Free PMC article. Review.
-
Interaction between peripheral blood mononuclear cells and Trypanosoma cruzi-infected adipocytes: implications for treatment failure and induction of immunomodulatory mechanisms in adipose tissue.Front Immunol. 2024 Mar 12;15:1280877. doi: 10.3389/fimmu.2024.1280877. eCollection 2024. Front Immunol. 2024. PMID: 38533504 Free PMC article.
-
Explicit mechanistic insights of Prosopis juliflora extract in streptozotocin-induced diabetic rats at the molecular level.Saudi Pharm J. 2023 Oct;31(10):101755. doi: 10.1016/j.jsps.2023.101755. Epub 2023 Aug 23. Saudi Pharm J. 2023. PMID: 37727228 Free PMC article.
-
Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management.Front Pharmacol. 2023 Jun 20;14:1182937. doi: 10.3389/fphar.2023.1182937. eCollection 2023. Front Pharmacol. 2023. PMID: 37408757 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources